Authors

• Wei‐Xiang Qi (ORCID: https://orcid.org/0000-0001-5484-3343)
• Dan Ou (ORCID: https://orcid.org/0000-0001-9485-6042)
• Xiaoyu Wu (ORCID: https://orcid.org/0000-0003-4038-9340)
• Han Zhao (ORCID: https://orcid.org/0000-0001-5781-9779)
• Lu Cao (ORCID: https://orcid.org/0000-0001-6644-0963)
• Feifei Xu (ORCID: https://orcid.org/0000-0001-8974-9867)
• Huan Li (ORCID: https://orcid.org/0000-0002-9254-3904)
• Mei Chen (ORCID: https://orcid.org/0000-0001-6809-147X)
• Yibin Zhang (ORCID: https://orcid.org/0009-0008-9862-8803)
• Shujun Zhang (ORCID: https://orcid.org/0000-0002-9103-7671)
• Gang Cai (ORCID: https://orcid.org/0000-0003-3323-1932)
• Jing Yang (ORCID: https://orcid.org/0000-0003-2021-3065)
• Keman Liao

Institutions

• Ruijin Hospital (CN)
• Shanghai Genon Biological Products (China) (CN)

Publication Details

Journal

International Journal of Particle Therapy

Published

2025-05-26

DOI

https://doi.org/10.1016/j.ijpt.2025.100752

Primary Topic

Breast Cancer Treatment Studies

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Shanghai Municipal Health Commission
• National Natural Science Foundation of China
• Shanghai Hospital Development Center
• Shanghai Aerospace Science and Technology Innovation Foundation
• National Key Research and Development Program of China
• Science and Technology Innovation Plan Of Shanghai Science and Technology Commission